Clinical Trials Logo

Clinical Trial Summary

Intracranial cavernous vascular malformations are variously known as cavernous angiomas, cavernous hemangiomas, or, more simply, cavernomas. Cavernomas are congenital low flow vascular lesions. It composed of irregular sinusoidal vascular channels, lacking smooth muscle, and elastic fibers. They lack feeding arteries or draining veins and contain no neural tissue. The first description of an intracranial cavernoma was given by Virchow, in 1863. For over a century, it was considered to be an extremely rare malformation, usually found at autopsy, and exceptionally diagnosed during life. The prevalence of cerebral cavernous malformations (CCM) is estimated to be 0.4-0.9%.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms

  • Hemangioma
  • Management of Intracranial Cavernous Hemangioma

NCT number NCT04181086
Study type Observational
Source Assiut University
Contact
Status Not yet recruiting
Phase
Start date January 1, 2020
Completion date January 1, 2022